Logipharma 2016 (past event)
19 - 21 April, 2016
44 (0) 20 7368 9854
Conference day two - Wednesday 20 April 2016
08:15 - 08:50 Welcome Coffee
08:50 - 09:00 Chairman’s opening address
09:00 - 09:40 ALL STAR PANEL: How can you influence senior management and the commercial team to implement a new segmentation strategy and add commercial value to the business?
Speakers:
Manfred Bruch Head of Partner Collaborations, Global Tech Ops, Supply Chain F. Hoffmann-La Roche
Mike Broughton Director, Global Logistics Eli Lilly
Tom Atkinson Head of Strategy & Transformation, Global Supply Chain at AZ AstraZeneca
Moderator:
Simon Orchard Vice President, EMEA Supply Operations & Customer Support Pfizer
Manfred Bruch Head of Partner Collaborations, Global Tech Ops, Supply Chain F. Hoffmann-La Roche
Mike Broughton Director, Global Logistics Eli Lilly
Tom Atkinson Head of Strategy & Transformation, Global Supply Chain at AZ AstraZeneca
Moderator:
Simon Orchard Vice President, EMEA Supply Operations & Customer Support Pfizer
A truly engaging panel of pharma supply chain leaders discuss their latest strategies to increase put supply chain towards the forefront within their company.
• To what extent can segmentation significantly improve customer service and can it really add commercial value?
• How can supply chain influence the commercial team to implement a segmented strategy?
• How can you make sure segmentation will reduce costs to ensure it is really worth the investment?
• What can pharma learn from FMCG in segmentation through distribution channels?
F. Hoffmann-La Roche
• To what extent can segmentation significantly improve customer service and can it really add commercial value?
• How can supply chain influence the commercial team to implement a segmented strategy?
• How can you make sure segmentation will reduce costs to ensure it is really worth the investment?
• What can pharma learn from FMCG in segmentation through distribution channels?
Manfred Bruch
Head of Partner Collaborations, Global Tech Ops, Supply ChainF. Hoffmann-La Roche
09:40 - 10:00 GSK’s story: How to achieve a fully integrated and cross functional Integrated Business Planning process through innovation to deliver a profitable, customer-centric service
Simon owns the global process for Sales & Operations Planning across the Pharmaceutical, Consumer Healthcare and Vaccines businesses. In his role, Simon uses his extensive experience of Integrated Business Planning, Supply Chain Management, Strategic Planning, Cost Reduction and Lean Six Sigma implementations from across multiple sectors to implement a highly successful and integrated strategy.
•What steps can you put in place to ensure your Integrated Business Planning process delivers profitability?
•How can you engage other business units to integrate information all the way from customer requirements throughout the supply chain?
•How can you best collect operational data for forecast vs. actual and how can you use this information?
•What steps can you put in place to ensure your Integrated Business Planning process delivers profitability?
•How can you engage other business units to integrate information all the way from customer requirements throughout the supply chain?
•How can you best collect operational data for forecast vs. actual and how can you use this information?
10:00 - 10:40 ALL STAR PANEL: How can you capitalise on the digital age to improve your customers’ experience and add value to the business?
Speakers:
Alessandro de Luca Global Head of Supply Network Operations and Vice President Merck
Carlo de Notaristefani Chief Executive Officer & President, Global Operations Teva Pharmaceuticals
Ulrich Glas Corporate Senior Vice President Supply Network & Lifecycle Management Boehringer Ingelheim
Moderator:
Marcus Hayek Managing Director Accenture Strategy
Alessandro de Luca Global Head of Supply Network Operations and Vice President Merck
Carlo de Notaristefani Chief Executive Officer & President, Global Operations Teva Pharmaceuticals
Ulrich Glas Corporate Senior Vice President Supply Network & Lifecycle Management Boehringer Ingelheim
Moderator:
Marcus Hayek Managing Director Accenture Strategy
Carlo de Notaristefani
Chief Executive Officer & President, Global OperationsTeva Pharmaceuticals
Ulrich Glas
Corporate Senior Vice President Supply Network & Lifecycle ManagementBoehringer Ingelheim
10:40 - 11:05 INTERVIEW: What do Pharma companies need from their supply chain partner in order to be truly customer centric and meet the needs of healthcare providers and patients?
•What steps can 3PLs put in place to communicate and align with pharma on customer-centricity?
•How can you measure customer-centricity?
•To what extent is it possible to prove customer satisfaction rather than just perceive it?
•How can 3PLs and pharma communicate to provide reassurance that customer needs are met?
•How can you measure customer-centricity?
•To what extent is it possible to prove customer satisfaction rather than just perceive it?
•How can 3PLs and pharma communicate to provide reassurance that customer needs are met?
Networking break
11:05 - 23:45 Morning networking breakMasterclass
11:05 - 23:45 MASTERCLASS- Demystifying digital for pharma supply chainsThe session will look at concrete examples of digital capabilities across the entire supply chain (planning, order management, warehousing, distribution) and discuss how they are changing the way supply chains operate. A debate on digital supply chain maturity will allow for identifying areas of improvement and sharing of ideas among the participants.
TRACK A - End-to-End Connectivity
23:45 - 23:50 Chairman’s opening addressTailored content for: VP/Director Supply Chain, Planning, IT, Sourcing
TRACK B - Customer Service and Distribution
23:45 - 23:50 Chairman’s opening addressTailored content for: VP/Director Supply Chain, Distribution, Sourcing
TRACK C - Serialisation, Security, Track and Trace
23:45 - 23:50 Chairman’s opening addressTailored content for: Director Logistics, Transportation, Warehousing, Distribution, Quality
SYNERGY WORKSHOPS- Limited to 25 attendees
23:45 - 23:50 Women in supply chain: How to accelerate you career trajectory and leadership pathCorina leads a team of 150 and also oversees the regional management for all internal and external logistics activities across Europe, Middle East, India and Africa. She recently has worked closely with site, regional and headquarters cross-functional teams to implement a global distribution strategy, recognizing the evolution of Bristol Myers Squibb portfolio towards the biopharma space.
Corina has relocated to Paris after 14 years abroad, holding site, regional and global Supply Chain roles in the USA and Italy providing her with a global culture-sensitive mindset in the pharma/biopharma industry. She is viewed as a leading pioneer in developing and motivating high performing teams, therefore best placing her to discuss supply chain talent management. Corina‘s key areas of responsibility are Change and Talent Management. Recently she has pioneered an extremely successful HR Transformation in a multinational global environment – ensuring global requirements were successfully translated into local needs. Corina has a wealth of knowledge in supply chain talent development, best placing her to lead a session on nurturing rising stars.
-
Why are women underrepresented in the supply chain and what can be done to overcome this?
-
What are the main priorities for women in accelerating their career path?
-
What experience should be gained to move to leadership?
-
How can you encourage more women to become involved in supply chain careers?
Track A
23:50 - 12:15 CASE STUDY INTERACTIVE: Risk management - How to analyse, manage and mitigate the risk of supply shortage
Gianpiero leads supply chain for the fill and finish manufacturing operations site, where he has direct responsibility for logistics, purchasing, production planning and sales & distribution. He ensures efficient site management processes through developing highly successful purchasing and procurement processes, and developing, recruiting for and leading an effective team.
•What should you prioritise investing in to mitigate risk with a limited budget?
•How should you weight the risk implications for regulatory compliance and quality?
•How can you quantify risk implications?
•What should you put in place to effectively monitor risk?
•What should you prioritise investing in to mitigate risk with a limited budget?
•How should you weight the risk implications for regulatory compliance and quality?
•How can you quantify risk implications?
•What should you put in place to effectively monitor risk?
Track B
23:50 - 12:15 AstraZeneca’s story: How to make strategic distribution decisions that will contribute to your organisation’s bottom-line-
How to reduce cost and ensuring reliability of logistics
-
Examining network design options
-
Becoming a part of the Enterprise supply chain strategy
-
How to add value to the top-line
Track C
23:50 - 12:15 Merck’s story: How to connect a fully integrated and compliant track and trace system to the outside world
Yves is the IT program lead of the Merck Track IT program. Working as business partner for the IS Manufacturing and Supply domain at Merck, he has extensive years of experience in the pharmaceutical business within corporate and site positions ranging from IS finance, supply chain and Pharmaceutical manufacturing.
•How to effectively incorporate physical and serialisation components across primary and secondary packaging
•How to build a specific programme to aggregate individual country compliance requirements: Case study on Trackit
•How to use cloud based technology to incorporate CMO onboarding and integration
•How to take advantage of digitization – including smart phone based applications
•How to effectively incorporate physical and serialisation components across primary and secondary packaging
•How to build a specific programme to aggregate individual country compliance requirements: Case study on Trackit
•How to use cloud based technology to incorporate CMO onboarding and integration
•How to take advantage of digitization – including smart phone based applications
Track D
23:50 - 12:15 SYNERGY WORKSHOP CONTINUEDTrack A
12:15 - 12:35 TRACK A CONTINUEDTrack B
12:15 - 12:35 Your wholesaler: How to optimise your product availability to best meet key customer requirements
• How can you assess the impact of product availability?
• What can you do to mitigate the risk of product availability?
• Case studies on pharmacy product availability in the UK and Czech Republic
• How to understand what your customers require and meet their needs effectively
• What can you do to mitigate the risk of product availability?
• Case studies on pharmacy product availability in the UK and Czech Republic
• How to understand what your customers require and meet their needs effectively
Track C
12:15 - 12:35 Latin America: What steps can you take to ensure your supply chain is secure in a large-scale and difficult environment
•What can you put in place to make sure that the products are not stolen or diverted?
•Where should you prioritise your investment?
•What legislation requirements will help to secure the product? •What has been learned and what would be done differently next time?
•Where should you prioritise your investment?
•What legislation requirements will help to secure the product? •What has been learned and what would be done differently next time?
Track D
12:15 - 12:35 SYNERGY WORKSHOP CONTINUEDLunch
12:35 - 13:45 Networking lunchMasterclass
12:35 - 13:45 MASTERCLASS - How IoT, Big Data and technology are reshaping pharma supply chain
Masterclass
12:35 - 13:45 MASTERCLASS - Balance Response and Optimization with OMP Plus to provide agility and visibility in a complex supply chain
Track A
13:45 - 14:05 ALL STAR PANEL: Should you prioritise flexibility or forecast accuracy to achieve your stable and efficient end-to-end supply chain?
This panel brings together top pharma planning practitioners to share their own experience and help you evaluate flexibility versus forecast accuracy.
•How do you balance the investment in a flexible versus a stable supply chain?
•To what extent should your strategy prioritise flexibility versus forecast accuracy?
•How should you assess and manage risk to achieve a stable supply chain?
•Is investing in flexibility or forecast accuracy most cost-effective?
•How do you balance the investment in a flexible versus a stable supply chain?
•To what extent should your strategy prioritise flexibility versus forecast accuracy?
•How should you assess and manage risk to achieve a stable supply chain?
•Is investing in flexibility or forecast accuracy most cost-effective?
Track B
13:45 - 14:05 CASE STUDY INTERACTIVE: Value Added Logistics: Bringing sustainable savings and customers satisfaction in Growth Pharma environment.
Track C
13:45 - 14:05 How can you prepare your serialisation network and tools to meet the EU Falsified Medicines Directive requirements?Emre is directly responsible for the management of supply chain activities in the Turkey & Middle East and Africa regions, serving as a single point of contact for supply chain activities in the region. Emre oversees the planning and coordination of new product launches in the region, advising and supporting regional partners and distributors, and the execution of regional supply chain strategies and supporting commercial activities in line with regional and global strategies.
-
What do you need to implement to visualise nodes end-to-end?
-
What are the priority requirements from each country?
-
How can you ensure that meeting the requirements is high on the business agenda?
-
How can pharma gain access to the right data in order to meet requirements?
Track A
14:05 - 14:25 TRACK A CONTINUEDTrack B
14:05 - 14:25 TRACK B CONTINUEDTrack C
14:05 - 14:25 How to meet challenging serialisation regulatory requirements - now and for the future, whilst managing vastly growing data volumes
•Determining the main dos and don’ts from present and predicted requirements
•What should be the main priorities for investment in serialisation? •What is required to map the pharma supply chain given its complexity?
•How to connect the dots across internal business processes
•How to manage vastly growing data volumes
•What should be the main priorities for investment in serialisation? •What is required to map the pharma supply chain given its complexity?
•How to connect the dots across internal business processes
•How to manage vastly growing data volumes
Track A
14:25 - 14:35 India: How to ensure supply chain integrity and secure cold chain management
Track B
14:25 - 14:35 How to work with healthcare distributors/wholesalers to achieve a globally integrated, customer-first distribution strategy
Track C
14:25 - 14:35 INNOVATION SPOTLIGHT: Ensuring the security of the supply chain by integrating a unique, innovative copy detection pattern into product labeling of primary containers
10 minute showcases from leading providers:
Cloud, RFID data logger, Mobile technology data logger
•What are the main advantages of the solution?
•What are the main disadvantages of the solution?
•What is the potential for integration with current systems?
•Which main requirements does the solution help to fulfil and why?
Ensuring the security of the supply chain by integrating a unique, innovative copy detection pattern into product labeling of primary containers
Cloud, RFID data logger, Mobile technology data logger
•What are the main advantages of the solution?
•What are the main disadvantages of the solution?
•What is the potential for integration with current systems?
•Which main requirements does the solution help to fulfil and why?
Ensuring the security of the supply chain by integrating a unique, innovative copy detection pattern into product labeling of primary containers
Track A
14:35 - 14:45 TRACK A CONTINUEDTrack B
14:35 - 14:45 TRACK B CONTINUEDTrack C
14:35 - 14:45 INNOVATION SPOTLIGHT: Global Serialisation: 4 key success factors to achieve compliance and ensure supplyTrack A
14:45 - 15:45 DRILL-DOWN ROUND TABLES: What do you need to know about working with local/regional providers and affiliate offices to achieve a globally integrated supply chain?
•What tips and tricks do you need to know about working in this region?
•What are the best ways for finding local 3PLs and wholesalers? •How can you best communicate with your affiliate offices?
•What are the best methods for integrating information gathered from across the region?
Table 1: US & Canada –
Patrycja Lakomiak, Global Distribution & Logistics: Global Distribution Program Manager, Takeda
•What are the best ways for finding local 3PLs and wholesalers? •How can you best communicate with your affiliate offices?
•What are the best methods for integrating information gathered from across the region?
Table 1: US & Canada –
Patrycja Lakomiak, Global Distribution & Logistics: Global Distribution Program Manager, Takeda
Table 2: Middle East special focus on Iran -
Esra Kostak Kutuk, Senior Supply Chain Manager, Novo Nordisk
Esra Kostak Kutuk, Senior Supply Chain Manager, Novo Nordisk
Table 3: India –
Rajesh Vij, Associate Vice President ( Imports / Exports), Wockhardt
Rajesh Vij, Associate Vice President ( Imports / Exports), Wockhardt
Track B
14:45 - 15:45 DRILL-DOWN ROUND TABLES: What do you need to achieve a first-class customer experience in your distribution channels?
•Which customer requirements should you prioritise for this channel?
•How can you best align distribution channel requirements between Supply Chain Management and Commercial?
•Which capabilities would a distribution partner of choice have to meet?
•What are the differences in how you implement your strategy product-to-product, market-to-market?
Table 1: Improving the customer experience for a future product portfolio -
Roeland Vandebrouck, Distribution Network Director, AstraZeneca
Table 2: Product launch -
Barbara Gros-Piron, Senior Manager PLM, Celgene
Anja Schulze, Global Distribution Operations Manager, Norgine Table 3: How can you optimise customer service for a high-value rare disease product? -
Barbara Polek, Head Supply Chain Management & Distribution, Santhera Pharmaceuticals
•How can you best align distribution channel requirements between Supply Chain Management and Commercial?
•Which capabilities would a distribution partner of choice have to meet?
•What are the differences in how you implement your strategy product-to-product, market-to-market?
Table 1: Improving the customer experience for a future product portfolio -
Roeland Vandebrouck, Distribution Network Director, AstraZeneca
Table 2: Product launch -
Barbara Gros-Piron, Senior Manager PLM, Celgene
Anja Schulze, Global Distribution Operations Manager, Norgine Table 3: How can you optimise customer service for a high-value rare disease product? -
Barbara Polek, Head Supply Chain Management & Distribution, Santhera Pharmaceuticals
Track C
14:45 - 15:45 DRILL-DOWN ROUND TABLES: What do you need to know to ensure global security and meet serialisation requirements?
•How can you keep up-to-date with the new regulations and new constraints?
•How to assess the complex regulations – what can and cannot be covered?
•How can you manage the cost of these requirements?
•What are the specific production and distribution requirements?
Table 1: Turkey and Middle East -
Emre Göllü, Senior Supply Chain Manager, Turkey & MEA Region, UCB Pharma
Table 2: How to meet the EU Falsified Medicines Directive requirements and lessons learned around the globe -
Haris Kamal, Vice President Life Sciences, Frequentz
Table 3: How can you ensure Brand Protection and Supply Chain Integrity? -
Manfred Voglmaier, Senior Director Sales EMEA, SYTECH International
Table 4: How to future-proof your serialization and track-and-trace strategy with standardized solutions -
Julien Boisnet, Senior Sales Director, Europe, Adents
•How to assess the complex regulations – what can and cannot be covered?
•How can you manage the cost of these requirements?
•What are the specific production and distribution requirements?
Table 1: Turkey and Middle East -
Emre Göllü, Senior Supply Chain Manager, Turkey & MEA Region, UCB Pharma
Table 2: How to meet the EU Falsified Medicines Directive requirements and lessons learned around the globe -
Haris Kamal, Vice President Life Sciences, Frequentz
Table 3: How can you ensure Brand Protection and Supply Chain Integrity? -
Manfred Voglmaier, Senior Director Sales EMEA, SYTECH International
Table 4: How to future-proof your serialization and track-and-trace strategy with standardized solutions -
Julien Boisnet, Senior Sales Director, Europe, Adents
15:45 - 16:15 Afternoon Networking Break
Track A
16:15 - 16:35 How to set up and operate the optimum global distribution network: Ensuring HQ and affiliate offices streamline country by country
Dean leads the logistics procurement, where he is currently focusing on Novo Nordisk’s global distribution strategy. Whilst defining the procurement strategy for the logistics category, his focus is not just about cost-control, it is also about enabling best practice country by country to ensure a fully integrated, end-to-end network. Niels leads the start-up of the Distribution Category in Novo Nordisk. He is directly responsible for developing and establishing collaboration with regions and sales affiliates pursuing contract and quality standards, while optimizing the downstream supply chain activities. In his role, Niels prioritises managing and developing procurement activities in a global context with many stakeholders.
•How do you decide what the HQ office will operate and what each affiliate office will operate?
•How to put processes in place to ensure decisions are made quickly and efficiently
•What are the best communication methods between HQ and affiliates?
•How to take into account the nuances and requirements of each country
•How do you decide what the HQ office will operate and what each affiliate office will operate?
•How to put processes in place to ensure decisions are made quickly and efficiently
•What are the best communication methods between HQ and affiliates?
•How to take into account the nuances and requirements of each country
Track B
16:15 - 16:35 How to work with your wholesalers and distributors to achieve the necessary distribution visibility and efficiencies
Richard is responsible for MSD's supply allocation system in Europe, the first such system in pharma. Richard is viewed as a leading pioneer in the ‘Route to Customer’ initiative, where he successfully completed projects to create efficiencies in the end-to-end supply chain. Richard has also identified the important of partnering with wholesalers to develop revenue-enhancing services capitalizing on the strengths of wholesalers in the trade channel.
•What are the opportunities to collaborate with wholesalers and distributors to increase visibility?
•How to work with the wholesaler to meet commercial needs outlined by the business
•How to ensure oversight of local distributors and wholesalers when the pharma company has no presence in the country
•What tools and technologies should you put in place to achieve visibility?
•What are the opportunities to collaborate with wholesalers and distributors to increase visibility?
•How to work with the wholesaler to meet commercial needs outlined by the business
•How to ensure oversight of local distributors and wholesalers when the pharma company has no presence in the country
•What tools and technologies should you put in place to achieve visibility?
Track C
16:15 - 16:35 Interview: What solutions can you implement to ensure global supply chain: Anti-counterfeiting, anti-theft and anti-tampering?16:35 - 16:40 5 minute transit time
16:40 - 17:00 How to develop methods to align your supply chain with the strategy of your internal business stakeholders
17:00 - 17:40 Counter-terrorist bomb disposal: An inspirational story of extreme pressure, deadly devices and the critical role of logistics
The Hurt Locker's real-life star, Major Chris Hunter QGM had 'the world's most dangerous job, in the world's most dangerous place'. As the British Army's most experienced counter-terrorist bomb disposal specialist in Iraq, he risked his life on a daily basis. So effective was he at defusing the crude, unstable but deadly devices, that terrorists on both sides of the conflict, Sunnis and Shi'ites, put a price on Chris' head. Quite apart from the danger of defusing the bombs, just getting to them was a risk, as Chris was a prime target for snipers. Chris joined the British Army as part of the Royal Logistic Corps (RLC) at sixteen, where he encountered the perceived stigma and undervaluation of the logistics function. During his career he deployed to a number of operational theatres, including The Balkans, Northern Ireland, Colombia, Afghanistan and Iraq, and for his actions during his Iraq tour, he was awarded the Queen's Gallantry Medal. Throughout his dangerous and dramatic military career, Chris has encountered situations where a highly valued and effective logistical operation could have saved him from extreme personal danger and even turned around the entire execution and perhaps the final result of some of history’s most well-known military operations. Chris rounded off his military career as a senior intelligence analyst at the Ministry of Defence. At the time of the London suicide bombings, he was seconded to COBRA, the Cabinet Office's emergency response committee. Chris illustrates a gruelling journey of bravery, strength, leadership and skill where every decision made during his time in Iraq could have been his last. Major Chris Hunter QGM, Iraq bomb disposal expert and inspiration behind Oscar-winning film The Hurt Locker
Inspiration behind Oscar-winning film The Hurt Locker
Major Chris Hunter QGM
Iraq bomb disposal expertInspiration behind Oscar-winning film The Hurt Locker